These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15752292)

  • 1. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Tsubouchi I; Okubo A
    J Dermatol; 2018 Oct; 45(10):1151-1159. PubMed ID: 30156314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats.
    Khoza S; Moyo I; Ncube D
    J Toxicol; 2017; 2017():6746989. PubMed ID: 28261269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of oral antifungal agent-induced liver injury in Taiwanese.
    Kao WY; Su CW; Huang YS; Chou YC; Chen YC; Chung WH; Hou MC; Lin HC; Lee FY; Wu JC
    Br J Clin Pharmacol; 2014 Jan; 77(1):180-9. PubMed ID: 23750489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic failure related to itraconazole use successfully treated by corticosteroids.
    Lou HY; Fang CL; Fang SU; Tiong C; Cheng YC; Chang CC
    Hepat Mon; 2011 Oct; 11(10):843-6. PubMed ID: 22224084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pH on transungual passive and iontophoretic transport.
    Smith KA; Hao J; Li SK
    J Pharm Sci; 2010 Apr; 99(4):1955-67. PubMed ID: 19904826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail.
    Smith KA; Hao J; Li SK
    Pharm Res; 2009 Jun; 26(6):1446-55. PubMed ID: 19267187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses.
    Gupta A; Lambert J; Revuz J; Shear N
    Eur J Dermatol; 2001; 11(1):6-10. PubMed ID: 11174129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 9. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.
    Tuccori M; Bresci F; Guidi B; Blandizzi C; Del Tacca M; Di Paolo M
    Ann Pharmacother; 2008 Jul; 42(7):1112-7. PubMed ID: 18523232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.
    Srebrnik A; Levtov S; Ben-Ami R; Brenner S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):205-7. PubMed ID: 15752292
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.